Kestenbaum Bryan, Rudser Kyle D, Shlipak Michael G, Fried Linda F, Newman Anne B, Katz Ronit, Sarnak Mark J, Seliger Stephen, Stehman-Breen Catherine, Prineas Ronald, Siscovick David S
Division of Nephrology, Harborview Medical Center, University of Washington, Seattle, WA 98104-2499, USA.
Clin J Am Soc Nephrol. 2007 May;2(3):501-8. doi: 10.2215/CJN.04231206. Epub 2007 Apr 11.
Chronic kidney disease (CKD) is associated with cardiovascular (CV) disease and mortality. It is not known whether cardiac rhythm disturbances are more prevalent among individuals with CKD or whether resting electrocardiogram findings predict future CV events in the CKD setting. Data were obtained from the Cardiovascular Health Study, a community-based study of adults aged >/=65 yr. After exclusions for prevalent heart disease, atrial fibrillation, implantable pacemaker, or antiarrhythmic medication use, 3238 participants were analyzed. CKD was defined by an estimated GFR <60 ml/min per 1.73 m(2). Outcomes were adjudicated incident heart failure (HF), incident coronary heart disease (CHD), and mortality. Participants with CKD had longer PR and corrected QT intervals compared with those without CKD; however, differences in electrocardiographic markers were explained by traditional CV risk factors and CV medication use. After adjustment for known risk factors, each 10-ms increase in the QRS interval was associated with a 15% greater risk for incident HF (95% confidence interval [CI] 1.04 to 1.27), a 13% greater risk for CHD (95% CI 1.04 to 1.24), and a 17% greater risk for mortality (95% CI 1.09, 1.25) among CKD participants. Each 5% increase in QTI was associated with a 42% (95% CI 1.23 to 1.65), 22% (95% CI 1.07 to 1.40), and 10% (95% CI 0.98 to 1.22) greater risk for HF, CHD, and mortality, respectively. Associations seemed stronger for participants with CKD; however, no significant interactions were detected. Resting electrocardiographic abnormalities are common in CKD and independently predict future clinical CV events in this setting.
慢性肾脏病(CKD)与心血管(CV)疾病及死亡率相关。目前尚不清楚心律失常在CKD患者中是否更普遍,也不清楚静息心电图检查结果能否预测CKD患者未来的心血管事件。数据来自心血管健康研究,这是一项针对年龄≥65岁成年人的社区研究。排除患有心脏病、心房颤动、植入式起搏器或使用抗心律失常药物的患者后,对3238名参与者进行了分析。CKD的定义为估算的肾小球滤过率(GFR)<60 ml/(min·1.73 m²)。观察终点为新发心力衰竭(HF)、新发冠心病(CHD)和死亡率。与无CKD的参与者相比,CKD参与者的PR间期和校正QT间期更长;然而,心电图指标的差异可由传统心血管危险因素和心血管药物使用情况来解释。在对已知危险因素进行校正后,CKD参与者的QRS间期每增加10毫秒,发生HF的风险增加15%(95%置信区间[CI]为1.04至1.27),发生CHD的风险增加13%(95%CI为1.04至1.24),死亡风险增加17%(95%CI为1.09至1.25)。QT间期每增加5%,发生HF、CHD和死亡的风险分别增加42%(95%CI为1.23至1.65)、22%(95%CI为1.07至1.40)和10%(95%CI为0.98至1.22)。这些关联在CKD参与者中似乎更强;然而,未检测到显著的交互作用。静息心电图异常在CKD中很常见,并且在此情况下可独立预测未来的临床心血管事件。